Fucosylated glycans of taenia crassiceps polarize immune responses towards Th-1 type via toll like receptor (TLR) signaling and interferon-gamma production

Emirates Medical Journal

Volumn 24, Issue 1, 2006, Pages 47-56

  Dissanayake, Senarath ^a   Shahin, Allen ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCAN DERIVATIVE; INTERLEUKIN 6; TOLL LIKE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FUCOSYLATION; HELMINTHIASIS; HOST PARASITE INTERACTION; IMMUNOREGULATION; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; POLARIZATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TAENIA CRASSICEPS; TH1 CELL; TH2 CELL;

EID: 33745698505     PISSN: 02506882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Shtrichman R and Samuel CE: The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol, 2001; 4: 251-259.
2. Medzhitov R and Janeway CA Jr: Innate immunity: the virtues of a nonclonal system of recognition. Cell, 1997; 91: 295-298.
3. Akira S, Takeda K and Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol, 2001; 2: 675-680.
4. Gryzch JM, Pearce EJ, Cheever A, et al: Egg deposition is a major stimulus for the production of Th-2 cytokines in murine Schistosoma mansoni. J Immunol, 1991; 146: 1322-1327.
5. Wynn TA, Eltoum I, Cheever AW, Lewis FA, Gause WC and Sher A: Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni. J Immunol, 1993; 151: 1430-1440.
6. Vella AT and Pearce EJ: CD+ Th-2 response induced by Schistosoma mansoni eggs develops rapidly through an early transient Th0 like stage. J Immunol, 1992; 148: 2283-2290.
7. Robinson BW, McLemore TL and Crystal RG: Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest, 1985; 75: 1488-1495.
8. Frucht DM, Fukao T, Bogdan C, Schindler H, O'Shea JJ and Koyasu S: IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol, 2001; 22: 556-560.
9. + lymphoid dendritic cells. J Exp Med, 1999; 189: 1981-1986.
10. Yeaman GR, Collins JE, Currie JK, Guyre PM, Wira CR and Fanger MW: IFN-gamma is produced by polymorphonuclear neutrophils in human uterine endometrium and by cultured peripheral blood polymorphonuclear neutrophils. J Immunol, 1998; 160: 5145-53.
11. Martin MU and Wesche H: Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim Biophys Acta, 2002; 1592: 265-280.
12. Lien E, Sellati TJ, Yoshimura A, Flo TH, et al: Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem, 1999; 274: 33419-33425.
13. Nyame AK, Kawar ZS and Cummings RD: Antigenic glycans in parasitic infections: implications for vaccines and diagnostics. Arch Biochem Biophys, 2004; 426: 182-200.
14. Chen L, Zhang ZH, Watanabe T, Yamashita T, et al: The involvement of neutrophils in the resistance to Leishmania major infection in susceptible but not in resistant mice. Parasitol Int, 2005; 54: 109-118.
15. Suzuki Y, Claflin J, Wang X, Lengi A and Kikuchi T: Microglia and macrophages as innate producers of interferon-gamma in the brain following infection with Toxoplasma gondii. Int J Parasitol, 2005; 35: 83-90.
16. Fenton MJ, Vermeulen MW, Kim S, Burdick M, Strieter RM and Kornfeld H. Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect Immunol, 1997; 65: 5149-5156.
17. Flesch IE, Hess JH, Huang S, et al: Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J Exp Med, 1995; 181: 1615-1621.
18. Salins S, Newton C, Widen R, Klein TW and Friedman H: Differential induction of gamma interferon in Legionella pneumophila-infected macrophages from BALB/c and A/J mice. Infect Immun, 2001; 69: 3605-3610.
19. + cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma. J Immunol, 2004; 172: 2407-2415.
20. Rothfuchs AG, Trumstedt C, Wigzell H and Rottenberg ME: Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling. J Immunol, 2004; 172: 6345-6353.
21. Kirby AC, Yrlid U and Wick MJ: The innate immune response differs in primary and secondary Salmonella infection. J Immunol, 2002; 169: 4450-4459.
22. Dissanayake S, Khan N, Shahin A, Wijesinghe S and Lukic M: Induction of immunoglobulin G1, interleukin-6 and interleukin-10 by Taenia crassiceps metacestode carbohydrates. Immunology, 2002; 107: 411-419.
23. Dissanayake S, Amith RS and Shahin A: Taenia crassiceps carbohydrates stimulate IL-6 expression in naive murine macrophages via Toll-like receptors (TLRs). Mol Immunol, 2004; 41: 391-398.
24. Dissanayake S, Shahin A and Ameen AM: Adjuvant effect of Taenia crassiceps glycans against leishmanial antigens in mice infected with Leishmania mexicana. Mol Immunol, 2005; 42: 1495-1502.
25. Dissanayake S. Immunomodulaqtion in parasitic infections: Parasite products as prototype immunotherapeutic agents. Emirates Med. J. 2005; 23: 119-126.
26. Lee JJ, Dissanayake S, Panico M, Morris HR, Dell A and Haslam SM: Mass spectrometric characterisation of Taenia crassiceps metacestode N-glycans. Mol Biochem Parasitol, 2005; 143: 245-249.
27. Okano M, Satoskar AR, Nishizaki K, Abe M and Harn DA J: Induction of Th2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma mansoni egg antigens. J Immunol, 1999; 163: 6712-6717.
28. Okano M, Satoskar AR, Nishizaki K and Ham DA Jr.: Lacto-N-fucopentaose III found on Schistosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response. J Immunol, 2001; 167: 442-450.
29. Atochina O and Harn D: LNFPIII/LeX-stimulated macrophages activate natural killer cells via CD40-CD40L interaction. Clin Diagn Lab Immunol, 2005; 12: 1041-1049.
30. Thomas PG, Carter MR, Atochina O, Da'Dara AA, Piskorska D, McGuire E and Harn DA. Maturation of dendritic cell 2 phenotype by a helminth glycan uses a Toll-like receptor 4-dependent mechanism. J Immunol, 2003; 171: 5837-5841.
31. Divanovic S, Trompette A, Atabani SF, Madan R, et al: Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat Immunol, 2005; 6: 571-578.
32. Divanovic S, Trompette A, Atabani SF, Madan R, et al: Inhibition of TLR-4/MD-2 signaling by RP105/MD-1. J Endotoxin Res, 2005; 11: 363-368.
33. Nagai Y, Shimazu R, Ogata H, Akashi S, et al: Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood, 2002; 99: 1699-705.
34. Hajjar AM, O'Mahony DS, Ozinsky A, Underhill DM, Aderem A, Klebanoff SJ and Wilson CB: Cutting edge: Functional interactions between toll like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol soluble modulin. J Immunol, 2001; 166: 15-19.
35. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L and Aderem A: The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA, 2000; 97: 13766-13771.
36. Muzio M, Bosisio D, Polentarutti N, D'amico G, et al: Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol, 2000; 164: 5998-6004.
37. Wysocka M, Kubin M, Vieira LQ, Ozmen L, Garotta G, Scott P and Trinchieri G. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol, 1995; 25: 672-676.
38. Zhou Q, Desta T, Fenton M, Graves DT, Amar S. Cytokine profiling of macropliages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect Immun, 2005; 73: 935-43.
39. Biondo C, Midiri A, Messina L, Tomasello F, et al: MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans. Eur J Immunol, 2005; 35: 870-878.
40. Lyons CR, Ball EJ, Toews GB, Weissler JC, Stastny P and Lipscomb MF: Inability of human alveolar macrophages to stimulate resting T cells correlates with decreased antigen-specific T cell-macrophage binding. J Immunol, 1986; 137: 1173-1180.
41. Blumenthal RL, Campbell DE, Hwang P, DeKruyff RH, Frankel LR and Umetsu DT: Human alveolar macrophages induce functional inactivation in antigen-specific CD4 T cells. J Allergy Clin Immunol, 2001; 107: 258-264.
42. Gordon S: Alternative activation of macrophages. Nat Rev Immunol, 2003: 3: 23-35.
43. Mosser D: The many faces of macrophage activation. J Leukoc Biol, 2003; 73: 209-212.
44. Verreck FA, de Boer T, Langenberg DM, van der Zanden L and Ottenhoff TH: Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-{gamma}- and CD40L-mediated costimulation. J Leukoc Biol, 2005 Dec 5;
45. Rutitzky LI, Hernadez HJ and Stadecker MJ: Th1 polarizing immunization with egg antigens correlates with severe exacerbation of immunopathology and death in schistosome infection. Proc Natl Acad Sci USA, 2001; 98: 13243-13248.
46. Herbert DR, Holscher C, Mohrs M, Arendse B, et al: Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity, 2004; 20: 623-635.
47. Mokuno Y, Matsuguchi T, Takano M, Nishimura H, et al: Expression of toll-like receptor 2 on gamma delta T cells bearing invariant V gamma 6/ V delta 1 induced by Escherichia coli infection in mice. J Immunol, 2000; 165: 931-940.
48. Matsuguchi T, Takagi K, Musikacharoen T and Yoshikai Y: Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes. Blood, 2000; 95: 1378-1385.
49. Hornung V, Rothenfusser S, Britsch S, Krug A, et al: Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol, 2002; 168: 4531-4537.
50. Sobek V, Birkner N, Falk I, Wurch A, et al: Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease. Arthritis Res Ther 2004; 6: R433-446.
51. Dalpke AH, Lehner MD, Hartung T and Heeg K: Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance. Immunology, 2005; 116: 203-212.
52. Curry H, Alvarez GR, Zwilling BS and Lafuse WP: Toll-like receptor 2 stimulation decreases IFN-gamma receptor expression in mouse RAW264.7 macrophages. J Interferon Cytokine Res, 2004; 24: 699-710.
53. Robinson P, Atmar RL, Lewis DE, White AC Jr. Granuloma cytokines in murine cysticercosis Infect Immun, 1997; 65: 2925-2931.
54. Londono DP, Alvarez JI, Trujillo J, Jaramillo MM and Restrepo BI: The inflammatory cell infiltrates in porcine cysticercosis: immunohistochemical analysis during various stages of infection. Vet Parasitol, 2002; 109: 249-259.
55. Restrepo BI, Alvarez JI, Castano JA, Arias LF, Restrepo M, Trujillo J, Colegial CH and Teale JM: Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infect Immun, 2001; 69: 4554-4560.
56. Restrepo BI, Llaguno P, Sandoval MA, Enciso JA and Teale JM: Analysis of immune lesions in neurocysticercosis patients: central nervous system response to helminth appears Th1-like instead of Th2. J Neuroimmunol, 1998; 89: 64-72.
57. Chavarria A, Fleury A, Garcia E, Marquez C, Fragoso G and Sciutto E: Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles. Clin Immunol, 2005; 116: 271-278.
58. Cortes I, Molinari JL, Solano S, Hernandez-Mendoza L, Ramirez A and Tato P: Taenia solium metacestode antigens which are protective for pigs induce Th1/Th2 mixed responses in mice. Parasitol Res, 2003; 90: 273-279.
59. Toenjes SA and Kuhn RE: The initial immune response during experimental cysticercosis is of the mixed Th1/Th2 type. Parasitol Res, 2003; 89: 407-413.
60. Terrazas LI, Cruz M, Rodriguez-Sosa M, Bojalil R, Garcia-Tamayo F and Larralde C: Th1-type cytokines improve resistance to murine cysticercosis caused by Taenia crassiceps. Parasitol Res, 1999; 85: 135-141.
61. Rodriguez-Sosa M, Saavedra R, Tenorio EP, Rosas LE, Satoskar AR and Terrazas LI: A STAT4-dependent Th1 response is required for resistance to the helminth parasite Taenia crassiceps. Infect Immun, 2004; 72: 4552-4560.
62. Schnare M, Barton, GM, Holt, AC, Takeda K, Akira S and Medzhitov R: Toll-like receptors control activation of adaptive immune responses. Nat Immunol, 2001; 2: 947-950.
63. Sieling PA, Chuang W, Duong BT, Godowski PJ and Modlin RL: Toll-like receptor 2 ligands as adjuvants for human Th1 responses. J Immunol, 2003; 170: 194-200.
64. Takeuchi O, Hoshino K, Kawai T, et al: Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity, 1999; 11: 443-451.
65. Gessani S and Belardelli F: IFN-gamma expression in macrophages and its possible biological significance. Cytokine Growth Factor Rev, 1998; 9: 117-123.
66. Diehl S and Rincon M: The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol, 2002; 39: 531-536.